Abstract:BACKGROUNDMany systemic therapies for advanced hepatocellular carcinoma (HCC) may cause hypothyroidism; however, in these patients, hypothyroidism prevalence before therapy and its prognostic impact remain unclear.METHODSWe previously established a prospective cohort of patients who received sorafenib as first-line therapy for advanced HCC. No patients had been clinically diagnosed with hypothyroidism before or during sorafenib treatment. We retrospectively determined the levels of thyrotropin and free thyroxine before initiation of systemic therapy. Hypothyroidism was defined as thyrotropin level higher than the upper limit of the normal range. Among patients with hypothyroidism, free thyroxine level less than the lower normal range was defined as overt hypothyroidism and free thyroxine level within the normal range as subclinical hypothyroidism.RESULTSIn total, 79 patients were enrolled; of them, 16 (20%) had hypothyroidism (overt hypothyroidism, 10; subclinical hypothyroidism, 6). Patients with hypothyroidism, compared with those without hypothyroidism, were more likely to be older than 65 years (56% vs. 29%, p = 0.037), have a serum α-fetoprotein level of >400 ng/mL (81% vs. 52%, p = 0.037), and a significantly poorer overall survival (OS; median, 5.5 vs. 11.6 months, p = 0.043). After adjusting for other potential prognostic factors, hypothyroidism remained an independent predictor for poorer OS (hazard ratio, 2.53, p = 0.018). Patients with overt hypothyroidism and subclinical hypothyroidism exhibited similarly poor OS (p = 0.768).CONCLUSIONUnderdiagnosis of hypothyroidism in patients with advanced HCC was common. Hypothyroidism, whether overt or subclinical, is associated with poor prognosis of advanced HCC.IMPLICATIONS FOR PRACTICEWe disclosed the underdiagnosis of hypothyroidism in patients with advanced HCC and its influence on prognosis. These findings implied the importance of thyroid function check before initiation of systemic therapy for patients with advanced HCC.

Clinical features of pulmonary hypertension associated with hyperthyroidism

Characteristics and Risk Factors of Pulmonary Hypertension in Patients With Hyperthyroidism

The Association of Autoantibodies in Hyperthyroid Heart Disease Combined with Pulmonary Hypertension

Pulmonary Hypertension As a Manifestation of Mitochondrial Disease

Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated with hyperthyroidism: case report and review of the literature.

Clinical Features and Long-Term Survival in Idiopathic Pulmonary Arterial Hypertension with Thyroid Dysfunction: Insights from a National Multicentre Prospective Study.

Clinical features of chronic obstructive pulmonary disease with pulmonary hypertension

Clinical characteristics and risk factors of pulmonary hypertension associated with chronic respiratory diseases: a retrospective study.

Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients

Clinical Features of Thyrotoxic Heart Disease: Analysis of 75 Cases

Clinical Characterizations and Severity Evaluation of Pulmonary Hypertension

An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma.

Pulmonary Hypertension Associated with Autoimmune Hemolytic Anemia: A Case Report

Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.

A peripheral system disease-Pulmonary hypertension

Hashitoxicosis with pericardial effusion

Clinical features and outcome of Takayasu arteritis associated pulmonary hypertension

Serum-Free Thyroxine Levels Were Associated with Pulmonary Hypertension and Pulmonary Artery Systolic Pressure in Euthyroid Patients with Coronary Artery Disease

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes

Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension

Pulmonary Hypertension and Hypothyroidism—Still an Important Clinical Coincidence in Paediatric Population, an Endocrinologist's Point of View